Emergent BioSolutions cuts 2026 revenue and EBITDA guidance as Q3 sales fall 52%Nov 2Quarterly updateAmgenAprea Therapeutics
Amgen posts results for rocatinlimab AD trial, daxdilimab myositis study; mCRPC trial terminatedAug 28Weekly roundup, 3 itemsacapatamabAmgen